Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Why SI Stock surged +4.93% Today — RQD Quant Desk Flash
Shoulder Innovations Inc. (SI) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is SI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Shoulder Innovations Inc. (NYSE: SI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $20.44 (+4.93% 1D, market cap $425.5M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, SI ranks #572 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does SI compare to CARL and OFIX in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), SI carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of 76.5%, and ROIC of -16.1%. By comparison, CARL (Carlsmed Inc.) holds a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $430.6M) and OFIX (Orthofix Medical Inc.) posts a D+ grade (55/100 RQD, P/E N/A, ROIC -12.2%, cap $417.1M). Among the 5-stock peer group, SI leads on earnings multiple (N/A) while OFIX leads on capital efficiency (-12.2% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for SI?
▼
Per SI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001699350), Shoulder Innovations Inc. generated $47.3M in revenue (+49.6% YoY), -$40.4M in net income, and -$36.0M in free cash flow against $169.9M in total assets and $14.9M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±11.3% realized swing band)
Altman Z-Score 8.73 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a SI Turnaround Squeeze
While SI currently carries a cautious 42/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($19.18) and Max Pain ($21.46) forces dealer call-delta covering toward $25.83.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why SI Stock surged +4.93% Today — RQD Quant Desk Flash
Shoulder Innovations Inc. (SI) surged +4.93% to $20.44, trading at 70% of its 52-week range ($10.92 – $24.6). Stretched risk/reward at current multiples (-16% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 70% of its 52-week range ($10.92 – $24.6) with RSI-14 at 50.8 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±11.3% around $20.44 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 76.5% gross margin and $0 annual free cash flow.
Oil slips more than 1% as talks continue on ending Iran war Reuters
Nine people dead in Learjet crash in south Florida, officials say Reuters
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SI)
- ✓Walkthrough of SI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
SI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +49.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on SI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for SI. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SI)
1. Head-to-Head Health Care Peer Comparison (SI vs. CARL, OFIX, NPCE, SSII)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Shoulder Innovations Inc. (SI) ranks #572 by composite RQD confidence (42/100, grade D-) and #471 by equity capitalization ($425.5M). Within this direct 5-issuer industry benchmark cohort, SI leads on earnings valuation at N/A trailing P/E, while OFIX leads on capital efficiency and profitability with -12.2% ROIC and 68.8% gross margin. OFIX currently holds the highest overall quantitative score in the immediate peer group at 55/100 (D+) compared with SI at 42/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| SI
ACTIVE
Shoulder Innovations Inc. | D- | 42/100 | — | 76.5% | -16.1% | +4.93% | $425.5M | Benchmark Subject |
| CARL Carlsmed Inc. | D- | 39/100 | — | 75.3% | -35.0% | +3.01% | $430.6M | /carl-vs-si → |
| OFIX Orthofix Medical Inc. | D+ | 55/100 | — | 68.8% | -12.2% | +1.99% | $417.1M | /ofix-vs-si → |
| NPCE Neuropace Inc. | E | 30/100 | — | 77.2% | -23.0% | +0.62% | $446.6M | /npce-vs-si → |
| SSII SS Innovations International Inc. | D- | 39/100 | — | 46.0% | -18.5% | -2.46% | $477.2M | /ssii-vs-si → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2024–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001699350In its most recent audited fiscal period (FY2025, filed 2025-12-31), Shoulder Innovations Inc. (SI) reported GAAP revenue of $47.3M (+49.6% vs. FY2024 revenue of $31.6M ) , GAAP net income of -$40.4M, operating cash flow of -$28.6M, and free cash flow of -$36.0M (-98.4% YoY). On the balance sheet, SI closed FY2025 with $169.9M in total assets against $14.9M in total debt (Altman Z-Score: 8.73, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $47.3M | -$40.4M | -$28.6M | -$36.0M | $169.9M | $14.9M |
| FY2024 (FY) | 2024-12-31 | $31.6M | -$15.6M | -$14.1M | -$18.2M | $43.1M | $14.7M |
3. SI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs SI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Shoulder Innovations Inc. (NYSE: SI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $20.44 (+4.93% 1D, market cap $425.5M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, SI ranks #572 in composite RQD confidence.
How does SI compare to CARL and OFIX in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), SI carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of 76.5%, and ROIC of -16.1%. By comparison, CARL (Carlsmed Inc.) holds a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $430.6M) and OFIX (Orthofix Medical Inc.) posts a D+ grade (55/100 RQD, P/E N/A, ROIC -12.2%, cap $417.1M). Among the 5-stock peer group, SI leads on earnings multiple (N/A) while OFIX leads on capital efficiency (-12.2% ROIC).
What are the biggest fundamental strengths and SEC risk factors for SI?
Per SI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001699350), Shoulder Innovations Inc. generated $47.3M in revenue (+49.6% YoY), -$40.4M in net income, and -$36.0M in free cash flow against $169.9M in total assets and $14.9M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is SI trading relative to its 50-day, 200-day, and 52-week technical levels?
SI last traded at $20.44 (+4.93% on volume of 144,839 shares), positioning the stock +6.57% above its 50-day simple moving average ($19.18) and +20.16% above its 200-day simple moving average ($17.01). Across its 52-week range of $10.92 to $24.60, SI sits at the 69.6% percentile with a 14-day RSI of 50.8 (NEUTRAL RANGE) and an implied next-earnings move of ±11.3% ($18.13 to $22.75).
SI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is SI stock moving today?
Why SI Stock surged +4.93% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-16% return on capital) under elevated 10-year interest-rate pressure.